Actelion (SWX: ATLN) went public in April 2000 and is developing therapies for severe cardiovascular diseases, including pulmonary arterial hypertension.
J&J gets a $30B Actelion buyout and a new partner as Clozel’s team spins out with the pipeline
Actelion is going public – Placement of up to 1 million shares – SWX New Market Listing
Location: Switzerland, Basel-City, Basel
Investors 1
| Date | Name | Website |
| - | Atlas Vent... | atlasventu... |
Mentions in press and media 5
| Date | Title | Description | Category | Author | Source |
| 29.11.2016 | Term Sheet... | Today in Fallen Unicorns Two ... | - | - | fortune.co... |
| 05.08.2014 | New pharma... | About 18 months ago, PatientsL... | - | - | medcitynew... |
| 20.06.2014 | What’s in ... | Christoph Schmidt, the head of... | - | - | medcitynew... |
| - | New pharma... | About 18 months ago, PatientsL... | - | - | medcitynew... |
| - | What’s in ... | Healthcare reform is prompting... | - | - | medcitynew... |